US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Armata Pharmaceuticals, Inc.

1.23

+0.05004.24%

Post-market: 1.230.00000.00%16:05 EDT

Volume:7.03K

Turnover:8.68K

Market Cap:44.51M

PE:-1.38

High:1.25

Open:1.25

Low:1.20

Close:1.18

Loading ...

Overview Company News Filings

New Strong Sell Stocks for April 9th

Armata Pharmaceuticals Q4 2024 GAAP EPS $(0.23) Beats $(0.35) Estimate, Sales $1.24M Miss $1.56M Estimate

BRIEF-Armata Pharmaceuticals Announces Fourth Quarter And Full-Year 2024 Results And Provides Corporate Update

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update

THOMSON REUTERS

Armata Pharmaceuticals Enters $10 Million Secured Credit Agreement with Innoviva

MT Newswires Live

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit

Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study

Armata Pharmaceuticals Announces Encouraging Results From the Phase 2 Tailwind Study of Inhaled AP-Pa02 in Non-Cystic Fibrosis Bronchiectasis Subjects With Chronic Pulmonary Pseudomonas Aeruginosa Infection

THOMSON REUTERS

Armata Pharmaceuticals Inc - One Possibly-Related Serious Adverse Event Linked to Acute Pulmonary Event

THOMSON REUTERS

Armata Pharmaceuticals Inc - Inhaled AP-Pa02 Well-Tolerated With Mild Adverse Events

THOMSON REUTERS

Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

BRIEF-Armata Pharmaceuticals Announces That CEO Dr. Deborah Birx Will Deliver A Presentation At The 5th Annual Phage Futures Annual Meeting

Armata Pharmaceuticals Announces That CEO DR. Deborah Birx Will Deliver a Presentation at the 5TH Annual Phage Futures Annual Meeting

THOMSON REUTERS

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting

Armata Pharmaceuticals Q3 EPS $(0.15) Beats $(0.28) Estimate, Sales $2.97M Beat $900.00K Estimate

Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update

Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia

Armata Pharmaceuticals Announces Structural Biology Publication

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARMP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARMP\",,,,,undefined,":{"symbol":"ARMP","market":"US","secType":"STK","nameCN":"Armata Pharmaceuticals, Inc.","latestPrice":1.23,"timestamp":1744920000000,"preClose":1.18,"halted":0,"volume":7030,"hourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"16:05 EDT","volume":1,"amount":1.23,"timestamp":1744920306634},"delay":0,"floatShares":11035220,"shares":36183067,"eps":-0.888605,"marketStatus":"Closed Good Friday","change":0.05,"latestTime":"04-17 16:00:00 EDT","open":1.25,"high":1.25,"low":1.2009,"amount":8676.7643,"amplitude":0.04161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.888605,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.18,"postHourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"16:05 EDT","volume":1,"amount":1.23,"timestamp":1744920306634},"volumeRatio":0.30218623041793524,"impliedVol":0.0619,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARMP\",,,,,undefined,":{"symbol":"ARMP","floatShares":11035220,"roa":"-28.70%","roe":"-3439.35%","lyrEps":-0.523107,"volumeRatio":0.30218623041793524,"shares":36183067,"dividePrice":0,"high":1.25,"amplitude":0.04161,"preClose":1.18,"low":1.2009,"week52Low":0.8981,"pbRate":"-0.93","psRate":"8.60","week52High":3.45,"institutionHeld":0.0555,"latestPrice":1.23,"eps":-0.888605,"divideRate":0,"volume":7030,"delay":0,"ttmEps":-0.888605,"open":1.25,"prevYearClose":1.85,"prevWeekClose":0.96,"prevMonthClose":1.46,"prevQuarterClose":1.46,"fiveDayClose":0.904,"twentyDayClose":2.01,"sixtyDayClose":2.19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARMP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526082354","title":"New Strong Sell Stocks for April 9th","url":"https://stock-news.laohu8.com/highlight/detail?id=2526082354","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526082354?lang=en_us&edition=fundamental","pubTime":"2025-04-09 17:24","pubTimestamp":1744190640,"startTime":"0","endTime":"0","summary":"Here are three stocks added to the Zacks Rank #5  List today:. Canadian Solar CSIQ is a leading manufacturer of solar photovoltaic modules and a provider of solar energy and battery energy storage solutions. The Zacks Consensus Estimate for its current year earnings has been revised 93.4% downward over the last 60 days.Armata Pharmaceuticals ARMP is a biotechnology company which is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The Zacks Consensus Estimate for its current year earnings has been revised 14.1% downward over the last 60 days.Darling Ingredients DAR is a provider of rendering, cooking oil and bakery waste recycling and recovery solutions. The Zacks Consensus Estimate for its current year earnings has been revised almost 11.4% downward over the last 60 days.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Day","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-sell-stocks-april-9th-092400777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARMP","CSIQ","DAR","LU2380233275.USD","BK4519","LU2211817866.USD","BK4585","BK4526","LU0256331488.USD","BK4141","BK4139","BK4588","LU1721429741.USD","LU2308191902.HKD","BK4189","LU1721429402.USD"],"gpt_icon":1},{"id":"2521497136","title":"Armata Pharmaceuticals Q4 2024 GAAP EPS $(0.23) Beats $(0.35) Estimate, Sales $1.24M Miss $1.56M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521497136","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521497136?lang=en_us&edition=fundamental","pubTime":"2025-03-21 06:00","pubTimestamp":1742508010,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.35) by 34.29 percent. This is a 58.18 percent increase over losses of $(0.55) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44427512/armata-pharmaceuticals-q4-2024-gaap-eps-0-23-beats-0-35-estimate-sales-1-24m-miss-1-56m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Armata Pharmaceuticals Q4 2024 GAAP EPS $(0.23) Beats $(0.35) Estimate, Sales $1.24M Miss $1.56M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP"],"gpt_icon":0},{"id":"2521541497","title":"BRIEF-Armata Pharmaceuticals Announces Fourth Quarter And Full-Year 2024 Results And Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2521541497","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521541497?lang=en_us&edition=fundamental","pubTime":"2025-03-21 05:59","pubTimestamp":1742507943,"startTime":"0","endTime":"0","summary":"BRIEF-Armata Pharmaceuticals Announces Fourth Quarter And Full-Year 2024 Results And Provides Corporate UpdateMarch 20 (Reuters) - Armata Pharmaceuticals Inc ARMP.A:ARMATA PHARMACEUTICALS ANNOUNCES FO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA5F0Q99:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2521497511","title":"Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2521497511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521497511?lang=en_us&edition=fundamental","pubTime":"2025-03-21 05:56","pubTimestamp":1742507816,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA5F0Q99:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2519393002","title":"Armata Pharmaceuticals Enters $10 Million Secured Credit Agreement with Innoviva","url":"https://stock-news.laohu8.com/highlight/detail?id=2519393002","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519393002?lang=en_us&edition=fundamental","pubTime":"2025-03-13 16:36","pubTimestamp":1741854977,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals  said late Wednesday it has entered into a secured credit agreement with Innoviva Strategic Opportunities, a subsidiary of its largest shareholder, Innoviva , for gross proceeds of $10 million.The term loan has an interest rate of 14% per annum and a maturity date of March 12, 2026.The company said it plans to use the proceeds to advance its lead therapeutic phage candidates, including AP-PA02 and AP-SA02, which target infectious caused by Pseudomonas aeruginosa and Staphylococcus aureus, respectively.The companies also entered into amendments to three previous credit and security agreements to extend their maturity dates to March 12, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","ARMP","INVA"],"gpt_icon":0},{"id":"2518748948","title":"Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748948","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748948?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:00","pubTimestamp":1741690800,"startTime":"0","endTime":"0","summary":"LOS ANGELES, March 11, 2025 /PRNewswire/ --Armata Pharmaceuticals, Inc.  , a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announcedthat Dr.Deborah Birx, Chief Executive Officer, will deliver a presentation at 9:00am ET on Thursday, March 13, 2025at the 7th Annual Bacteriophage Therapy Summit, being held inBoston, MA.Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates forPseudomonas aeruginosa,Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage therapy with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-ceo-dr-110000998.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-ceo-dr-110000998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4211","SMMF","ARMP"],"gpt_icon":0},{"id":"2492810672","title":"Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492810672","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492810672?lang=en_us&edition=fundamental","pubTime":"2024-12-20 00:56","pubTimestamp":1734627360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 19, 2024 11:56 ET (16:56 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP"],"gpt_icon":0},{"id":"2492124194","title":"Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2492124194","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492124194?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:15","pubTimestamp":1734610542,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals (ARMP) announced “encouraging” topline results from its Phase 2 trial evaluating AP-PA02, a novel, inhaled multi-phage thera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/armata-pharmas-inhaled-ap-pa02-shows-positive-results-in-phase-2-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/armata-pharmas-inhaled-ap-pa02-shows-positive-results-in-phase-2-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2492712910","title":"Armata Pharmaceuticals Announces Encouraging Results From the Phase 2 Tailwind Study of Inhaled AP-Pa02 in Non-Cystic Fibrosis Bronchiectasis Subjects With Chronic Pulmonary Pseudomonas Aeruginosa Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2492712910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492712910?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2NS7KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2492258129","title":"Armata Pharmaceuticals Inc - One Possibly-Related Serious Adverse Event Linked to Acute Pulmonary Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2492258129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492258129?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2NS7KK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2492129283","title":"Armata Pharmaceuticals Inc - Inhaled AP-Pa02 Well-Tolerated With Mild Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2492129283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492129283?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA2NS7KK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2492121074","title":"Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121074","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492121074?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609600,"startTime":"0","endTime":"0","summary":"Results demonstrate that inhaled AP-PA02 provides a durable reduction of Pseudomonas aeruginosa in the lung, with a favorable safety and tolerability profile. LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc.  , a biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for chronic pulmonary diseases and antibiotic-resistant bacterial pathogens, today announced encouraging topline results from its Phase 2  trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa  infections in non-cystic fibrosis bronchiectasis  patients. This is the second successful clinical trial AP-PA02,Armata's lead pulmonary candidate, which was first evaluated in cystic fibrosis patients in the Phase 1b/2a SWARM-P.a. trial, completed in 2023.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-encouraging-results-120000596.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-encouraging-results-120000596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2484691007","title":"BRIEF-Armata Pharmaceuticals Announces That CEO Dr. Deborah Birx Will Deliver A Presentation At The 5th Annual Phage Futures Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2484691007","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484691007?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:07","pubTimestamp":1732018061,"startTime":"0","endTime":"0","summary":"BRIEF-Armata Pharmaceuticals Announces That CEO Dr. Deborah Birx Will Deliver A Presentation At The 5th Annual Phage Futures Annual MeetingNov 19 (Reuters) - Armata Pharmaceuticals Inc ARMP.A:ARMATA P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA8WYTLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2484910143","title":"Armata Pharmaceuticals Announces That CEO DR. Deborah Birx Will Deliver a Presentation at the 5TH Annual Phage Futures Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2484910143","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484910143?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:00","pubTimestamp":1732017611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA8WYTLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2484910463","title":"Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2484910463","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484910463?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:00","pubTimestamp":1732017600,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Nov. 19, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc.  , a clinical-stage biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that Dr. Deborah Birx, Chief Executive Officer, will deliver a presentation at 1:15pm ET at the 5th Annual Phage Futures Annual Meeting, which is being held November 19th in Boston, MA.Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage therapy with drug development expertise that spans bench to","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-ceo-dr-120000871.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-ceo-dr-120000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ARMP"],"gpt_icon":0},{"id":"2483863106","title":"Armata Pharmaceuticals Q3 EPS $(0.15) Beats $(0.28) Estimate, Sales $2.97M Beat $900.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483863106","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483863106?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:31","pubTimestamp":1731533501,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 82.56 percent increase over losses of $(0.86) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41955790/armata-pharmaceuticals-q3-eps-0-15-beats-0-28-estimate-sales-2-97m-beat-900-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Armata Pharmaceuticals Q3 EPS $(0.15) Beats $(0.28) Estimate, Sales $2.97M Beat $900.00K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP"],"gpt_icon":0},{"id":"2483347863","title":"Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483347863","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483347863?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:05","pubTimestamp":1731531900,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Nov. 13, 2024 /PRNewswire/ --Armata Pharmaceuticals, Inc.  , a biotechnology company focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its third quarter ended September 30, 2024, and provided a corporate update.Completed enrollment of the Phase 2 study  of inhaled AP-PA02 in patients with non-cystic fibrosis bronchiectasis  and chronic pulmonary Pseudomonas aeruginosa  infection.Working towards initiating a pivotal bronchiectasis trial in 2025 for chronic pulmonary P. aeruginosa infection.\"During the third quarter, we completed enrollment of our Phase 2 Tailwind study of inhaled AP-PA02 in NCFB patients with chronic P. aeruginosa infection, and remain on-track to report topline data from this study by the end of this year,\" stated Dr. Deborah Birx, Chief Executive Officer of Armata. \"This will mark our second Phase 2 data readout for inhaled AP-PA0","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-third-quarter-210500052.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-third-quarter-210500052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2483080726","title":"Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483080726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483080726?lang=en_us&edition=fundamental","pubTime":"2024-11-13 00:10","pubTimestamp":1731427800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2024 11:10 ET (16:10 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP"],"gpt_icon":0},{"id":"2482962708","title":"Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia","url":"https://stock-news.laohu8.com/highlight/detail?id=2482962708","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482962708?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"Topline data anticipated in Q1 2025 to support potential initiation of a pivotalbacteremia efficacy trial in 2025. LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc.  , a clinical-stage biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that it has achieved full enrollment  of its Phase 1b/2a diSArm study of intravenous AP-SA02 as a potential treatment for Staphylococcus aureus  bacteremia. Armata anticipates topline data from the diSArm study in the first quarter of 2025.\"S. aureus continues to be cited by the World Health Organization and other health regulatory agencies as a high priority pathogen due to its evolving resistance to modern antibiotics and the significant socioeconomic challenges that it poses to healthcare systems,\" stated Mina Pastagia, MD, MS, Chief Medical Officer of Armata. \"Results from diSArmwill be an important step forward in ou","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-completion-enrollment-120000689.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-completion-enrollment-120000689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARMP","BK4139"],"gpt_icon":0},{"id":"2479087072","title":"Armata Pharmaceuticals Announces Structural Biology Publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2479087072","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479087072?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:00","pubTimestamp":1730286000,"startTime":"0","endTime":"0","summary":"Publication describes the structure of phage Pa193, a top candidate for inclusion intoArmata's multi-phage anti-Pseudomonas clinical products. LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc.  , a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced a paper in Communications Biology, published by Nature Portfolio.\"We are very pleased to simultaneously advance the fundamental understanding of phage structure while remaining laser focused on phage function in full clinical development. One of our phage clinical candidates contributed to the important learnings from this study,\" stated Dr. Deborah Birx, Chief Executive Officer of Armata. \"As we continue to advance our proprietary development programs, which are founded on uncompromising science and rigorously designed clinical trials, this study furthers our understanding of ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bM9_lM13MlbF4vIGK1JZvg--~B/aD0yMzM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c5ae7fba5bf4523a1183526f430008d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-structural-biology-110000443.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/armata-pharmaceuticals-announces-structural-biology-110000443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4093","ARMP","CF","BK4139","BK4585","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"ARMP","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-11-13","symbol":"ARMP","fiscalQuarterEnding":"2024/09","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-08-13","symbol":"ARMP","fiscalQuarterEnding":"2024/06","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-05-07","symbol":"ARMP","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2024-03-21","symbol":"ARMP","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARMP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1629259200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARMP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARMP","date":"2025-04-17","current":-2.257138,"percent":0.675081,"low":-8.421784,"twenty":-4.936663,"median":-2.990655,"eighty":-1.74079,"high":-0.932507,"avg":-3.325443,"sd":1.681652,"marketCap":42696019},"quantilePoints":[{"date":"2020-04-24","current":-2.995939,"twenty":-3.413418,"median":-2.55042,"eighty":-1.99774,"marketCap":58357889},{"date":"2020-05-01","current":-3.354877,"twenty":-3.406743,"median":-2.565785,"eighty":-1.998819,"marketCap":65349648},{"date":"2020-05-08","current":-3.120371,"twenty":-3.403276,"median":-2.585439,"eighty":-2.003247,"marketCap":60781699},{"date":"2020-05-15","current":-2.776374,"twenty":-3.386411,"median":-2.596309,"eighty":-2.003704,"marketCap":57798548},{"date":"2020-05-22","current":-2.955495,"twenty":-3.371732,"median":-2.619636,"eighty":-2.004682,"marketCap":61527486},{"date":"2020-05-29","current":-3.331648,"twenty":-3.389784,"median":-2.640161,"eighty":-2.008595,"marketCap":69358257},{"date":"2020-06-05","current":-3.439121,"twenty":-3.403297,"median":-2.667739,"eighty":-2.01568,"marketCap":71595621},{"date":"2020-06-12","current":-3.233132,"twenty":-3.406766,"median":-2.677055,"eighty":-2.018661,"marketCap":67307341},{"date":"2020-06-19","current":-3.55555,"twenty":-3.412253,"median":-2.717374,"eighty":-2.024576,"marketCap":74019431},{"date":"2020-06-26","current":-3.761539,"twenty":-3.415178,"median":-2.735021,"eighty":-2.027557,"marketCap":78307710},{"date":"2020-07-02","current":-3.546594,"twenty":-3.421245,"median":-2.766892,"eighty":-2.032328,"marketCap":73832984},{"date":"2020-07-10","current":-3.582418,"twenty":-3.433096,"median":-2.819915,"eighty":-2.033521,"marketCap":74578772},{"date":"2020-07-17","current":-3.537637,"twenty":-3.445715,"median":-2.843544,"eighty":-2.038291,"marketCap":73646537},{"date":"2020-07-24","current":-3.430165,"twenty":-3.459111,"median":-2.861935,"eighty":-2.044255,"marketCap":71409174},{"date":"2020-07-31","current":-3.331648,"twenty":-3.450538,"median":-2.919365,"eighty":-2.048759,"marketCap":69358257},{"date":"2020-08-07","current":-3.268956,"twenty":-3.459111,"median":-2.938508,"eighty":-2.055817,"marketCap":68053129},{"date":"2020-08-14","current":-3.028475,"twenty":-3.450538,"median":-2.951305,"eighty":-2.057375,"marketCap":64594335},{"date":"2020-08-21","current":-2.853418,"twenty":-3.448227,"median":-2.951305,"eighty":-2.064292,"marketCap":60860558},{"date":"2020-08-28","current":-2.748384,"twenty":-3.445715,"median":-2.936474,"eighty":-2.068645,"marketCap":58620292},{"date":"2020-09-04","current":-2.590834,"twenty":-3.443904,"median":-2.919365,"eighty":-2.083614,"marketCap":55259893},{"date":"2020-09-11","current":-2.932194,"twenty":-3.440912,"median":-2.919365,"eighty":-2.094348,"marketCap":62540758},{"date":"2020-09-18","current":-2.975958,"twenty":-3.438266,"median":-2.927817,"eighty":-2.11343,"marketCap":63474202},{"date":"2020-09-25","current":-2.730879,"twenty":-3.434246,"median":-2.919365,"eighty":-2.12655,"marketCap":58246914},{"date":"2020-10-02","current":-2.765803,"twenty":-3.430877,"median":-2.88954,"eighty":-2.13967,"marketCap":58991803},{"date":"2020-10-09","current":-2.775781,"twenty":-3.426174,"median":-2.870924,"eighty":-2.146826,"marketCap":59204628},{"date":"2020-10-16","current":-2.905935,"twenty":-3.422298,"median":-2.866429,"eighty":-2.15756,"marketCap":61980691},{"date":"2020-10-23","current":-3.04598,"twenty":-3.421428,"median":-2.88843,"eighty":-2.171872,"marketCap":64967712},{"date":"2020-10-30","current":-2.730879,"twenty":-3.421281,"median":-2.870924,"eighty":-2.176887,"marketCap":58246914},{"date":"2020-11-06","current":-2.958452,"twenty":-3.420012,"median":-2.870924,"eighty":-2.182555,"marketCap":63100824},{"date":"2020-11-13","current":-3.388956,"twenty":-3.420012,"median":-2.88954,"eighty":-2.195953,"marketCap":68263743},{"date":"2020-11-20","current":-2.906066,"twenty":-3.416792,"median":-2.906066,"eighty":-2.204851,"marketCap":58536893},{"date":"2020-11-27","current":-2.943205,"twenty":-3.415178,"median":-2.915351,"eighty":-2.207118,"marketCap":59284969},{"date":"2020-12-04","current":-2.887497,"twenty":-3.415139,"median":-2.915351,"eighty":-2.219374,"marketCap":58162856},{"date":"2020-12-11","current":-2.62753,"twenty":-3.41395,"median":-2.910709,"eighty":-2.237631,"marketCap":52926328},{"date":"2020-12-18","current":-2.562538,"twenty":-3.412253,"median":-2.906001,"eighty":-2.259528,"marketCap":51617197},{"date":"2020-12-24","current":-2.683237,"twenty":-3.411156,"median":-2.896782,"eighty":-2.290561,"marketCap":54048441},{"date":"2020-12-31","current":-2.771347,"twenty":-3.406766,"median":-2.88954,"eighty":-2.295499,"marketCap":55823250},{"date":"2021-01-08","current":-3.203172,"twenty":-3.406649,"median":-2.896782,"eighty":-2.301703,"marketCap":64521496},{"date":"2021-01-15","current":-3.119611,"twenty":-3.403297,"median":-2.901358,"eighty":-2.301703,"marketCap":62838326},{"date":"2021-01-22","current":-3.166034,"twenty":-3.396132,"median":-2.906066,"eighty":-2.30184,"marketCap":63773421},{"date":"2021-01-29","current":-5.014034,"twenty":-3.406672,"median":-2.915351,"eighty":-2.302233,"marketCap":100997693},{"date":"2021-02-05","current":-5.708442,"twenty":-3.4151,"median":-2.919215,"eighty":-2.329201,"marketCap":114985154},{"date":"2021-02-12","current":-6.229248,"twenty":-3.421245,"median":-2.919993,"eighty":-2.34586,"marketCap":125475749},{"date":"2021-02-19","current":-5.861621,"twenty":-3.426174,"median":-2.923441,"eighty":-2.355801,"marketCap":118070623},{"date":"2021-02-26","current":-5.719148,"twenty":-3.440912,"median":-2.928414,"eighty":-2.368226,"marketCap":115200805},{"date":"2021-03-05","current":-4.593734,"twenty":-3.452251,"median":-2.938508,"eighty":-2.373339,"marketCap":92531594},{"date":"2021-03-12","current":-5.616838,"twenty":-3.485837,"median":-2.943205,"eighty":-2.377013,"marketCap":113139967},{"date":"2021-03-19","current":-5.993082,"twenty":-3.500368,"median":-2.947511,"eighty":-2.386554,"marketCap":132932555},{"date":"2021-03-26","current":-5.498344,"twenty":-3.511111,"median":-2.951897,"eighty":-2.399085,"marketCap":121958761},{"date":"2021-04-01","current":-5.329683,"twenty":-3.524633,"median":-2.953992,"eighty":-2.404258,"marketCap":118217695},{"date":"2021-04-09","current":-5.194754,"twenty":-3.537637,"median":-2.957652,"eighty":-2.404258,"marketCap":115224842},{"date":"2021-04-16","current":-4.610063,"twenty":-3.553236,"median":-2.967224,"eighty":-2.406241,"marketCap":102255812},{"date":"2021-04-23","current":-4.655039,"twenty":-3.558039,"median":-2.975958,"eighty":-2.429655,"marketCap":103253429},{"date":"2021-04-30","current":-4.610063,"twenty":-3.582418,"median":-3.002452,"eighty":-2.461392,"marketCap":102255812},{"date":"2021-05-07","current":-4.688772,"twenty":-3.61777,"median":-3.017481,"eighty":-2.46549,"marketCap":104001643},{"date":"2021-05-14","current":-4.403592,"twenty":-3.627198,"median":-3.02135,"eighty":-2.470794,"marketCap":99512363},{"date":"2021-05-21","current":-4.817463,"twenty":-3.635421,"median":-3.037227,"eighty":-2.47323,"marketCap":108865029},{"date":"2021-05-28","current":-4.414628,"twenty":-3.701729,"median":-3.040512,"eighty":-2.475311,"marketCap":99761768},{"date":"2021-06-04","current":-4.458774,"twenty":-3.755513,"median":-3.049675,"eighty":-2.47896,"marketCap":100759385},{"date":"2021-06-11","current":-5.065786,"twenty":-3.763895,"median":-3.053472,"eighty":-2.48344,"marketCap":114476628},{"date":"2021-06-18","current":-4.613286,"twenty":-3.873799,"median":-3.063213,"eighty":-2.490821,"marketCap":104251047},{"date":"2021-06-25","current":-4.414628,"twenty":-3.920176,"median":-3.063486,"eighty":-2.493615,"marketCap":99761768},{"date":"2021-07-02","current":-4.502921,"twenty":-4.23059,"median":-3.081538,"eighty":-2.503799,"marketCap":101757003},{"date":"2021-07-09","current":-4.425665,"twenty":-4.392555,"median":-3.087983,"eighty":-2.506436,"marketCap":100011172},{"date":"2021-07-16","current":-4.138714,"twenty":-4.381518,"median":-3.105016,"eighty":-2.507328,"marketCap":93526657},{"date":"2021-07-23","current":-4.414628,"twenty":-4.392555,"median":-3.119951,"eighty":-2.509351,"marketCap":99761768},{"date":"2021-07-30","current":-4.227006,"twenty":-4.381518,"median":-3.123498,"eighty":-2.509351,"marketCap":95521892},{"date":"2021-08-06","current":-4.21597,"twenty":-4.381518,"median":-3.14349,"eighty":-2.510842,"marketCap":95272488},{"date":"2021-08-13","current":-3.94685,"twenty":-4.381518,"median":-3.158657,"eighty":-2.516115,"marketCap":95048030},{"date":"2021-08-20","current":-3.929867,"twenty":-4.337372,"median":-3.164073,"eighty":-2.525399,"marketCap":94639049},{"date":"2021-08-27","current":-3.924689,"twenty":-4.315299,"median":-3.166329,"eighty":-2.529787,"marketCap":94514360},{"date":"2021-09-03","current":-3.686515,"twenty":-4.293226,"median":-3.16948,"eighty":-2.531091,"marketCap":88778660},{"date":"2021-09-10","current":-4.059309,"twenty":-4.293226,"median":-3.179187,"eighty":-2.533943,"marketCap":97756277},{"date":"2021-09-17","current":-3.986821,"twenty":-4.288812,"median":-3.196944,"eighty":-2.544226,"marketCap":96010630},{"date":"2021-09-24","current":-3.764181,"twenty":-4.284176,"median":-3.198232,"eighty":-2.546619,"marketCap":90648997},{"date":"2021-10-01","current":-3.748648,"twenty":-4.28241,"median":-3.203172,"eighty":-2.546619,"marketCap":90274930},{"date":"2021-10-08","current":-3.572606,"twenty":-4.27336,"median":-3.211378,"eighty":-2.546619,"marketCap":86035499},{"date":"2021-10-15","current":-3.572606,"twenty":-4.271153,"median":-3.221741,"eighty":-2.54798,"marketCap":86035499},{"date":"2021-10-22","current":-3.127325,"twenty":-4.269475,"median":-3.227437,"eighty":-2.55168,"marketCap":75312234},{"date":"2021-10-29","current":-3.313722,"twenty":-4.253075,"median":-3.221138,"eighty":-2.557787,"marketCap":79801043},{"date":"2021-11-05","current":-4.089236,"twenty":-4.235836,"median":-3.233762,"eighty":-2.561851,"marketCap":98476981},{"date":"2021-11-12","current":-3.846318,"twenty":-4.22811,"median":-3.244803,"eighty":-2.565136,"marketCap":91280827},{"date":"2021-11-19","current":-4.474056,"twenty":-4.253075,"median":-3.260497,"eighty":-2.570328,"marketCap":106178292},{"date":"2021-11-26","current":-5.957799,"twenty":-4.274703,"median":-3.266128,"eighty":-2.578918,"marketCap":141390480},{"date":"2021-12-03","current":-5.136033,"twenty":-4.289915,"median":-3.269278,"eighty":-2.58575,"marketCap":121888345},{"date":"2021-12-10","current":-5.66105,"twenty":-4.35503,"median":-3.277105,"eighty":-2.58705,"marketCap":134348043},{"date":"2021-12-17","current":-5.752357,"twenty":-4.39697,"median":-3.286958,"eighty":-2.589336,"marketCap":136514946},{"date":"2021-12-23","current":-6.459989,"twenty":-4.414628,"median":-3.30478,"eighty":-2.593024,"marketCap":153308452},{"date":"2021-12-31","current":-6.254547,"twenty":-4.432287,"median":-3.312774,"eighty":-2.597656,"marketCap":148432918},{"date":"2022-01-07","current":-6.779564,"twenty":-4.451049,"median":-3.322326,"eighty":-2.602086,"marketCap":160892616},{"date":"2022-01-14","current":-6.574123,"twenty":-4.466877,"median":-3.32717,"eighty":-2.606756,"marketCap":156017082},{"date":"2022-01-21","current":-6.254547,"twenty":-4.498506,"median":-3.340604,"eighty":-2.608374,"marketCap":148432918},{"date":"2022-01-28","current":-5.763771,"twenty":-4.568329,"median":-3.354877,"eighty":-2.609192,"marketCap":136785809},{"date":"2022-02-04","current":-5.843665,"twenty":-4.59323,"median":-3.363741,"eighty":-2.612942,"marketCap":138681850},{"date":"2022-02-11","current":-6.797456,"twenty":-4.610063,"median":-3.376429,"eighty":-2.618843,"marketCap":161317227},{"date":"2022-02-18","current":-6.486715,"twenty":-4.612641,"median":-3.38937,"eighty":-2.626149,"marketCap":153942725},{"date":"2022-02-25","current":-6.603243,"twenty":-4.624323,"median":-3.398819,"eighty":-2.627366,"marketCap":156708164},{"date":"2022-03-04","current":-6.486715,"twenty":-4.643795,"median":-3.406766,"eighty":-2.62753,"marketCap":153942725},{"date":"2022-03-11","current":-5.127224,"twenty":-4.668469,"median":-3.413667,"eighty":-2.634322,"marketCap":121679280},{"date":"2022-03-18","current":-7.046463,"twenty":-4.688772,"median":-3.415178,"eighty":-2.634598,"marketCap":163160853},{"date":"2022-03-25","current":-6.887221,"twenty":-4.722504,"median":-3.420212,"eighty":-2.642738,"marketCap":159473602},{"date":"2022-04-01","current":-7.953907,"twenty":-4.817463,"median":-3.421487,"eighty":-2.645999,"marketCap":184172724},{"date":"2022-04-08","current":-7.797948,"twenty":-4.879921,"median":-3.431056,"eighty":-2.645999,"marketCap":180561495},{"date":"2022-04-14","current":-7.844736,"twenty":-4.929019,"median":-3.438408,"eighty":-2.653506,"marketCap":181644863},{"date":"2022-04-22","current":-6.69064,"twenty":-5.058069,"median":-3.445124,"eighty":-2.659761,"marketCap":154921762},{"date":"2022-04-29","current":-7.197506,"twenty":-5.173298,"median":-3.453108,"eighty":-2.666362,"marketCap":166658259},{"date":"2022-05-06","current":-6.526883,"twenty":-5.272128,"median":-3.474107,"eighty":-2.668669,"marketCap":151129971},{"date":"2022-05-13","current":-5.382555,"twenty":-5.361533,"median":-3.486678,"eighty":-2.670455,"marketCap":142282458},{"date":"2022-05-20","current":-5.806055,"twenty":-5.385473,"median":-3.492947,"eighty":-2.680758,"marketCap":153477270},{"date":"2022-05-27","current":-5.696726,"twenty":-5.439211,"median":-3.50476,"eighty":-2.683261,"marketCap":150587261},{"date":"2022-06-03","current":-6.489077,"twenty":-5.480051,"median":-3.510769,"eighty":-2.685119,"marketCap":171532251},{"date":"2022-06-10","current":-6.236344,"twenty":-5.524357,"median":-3.519725,"eighty":-2.690054,"marketCap":164851521},{"date":"2022-06-17","current":-4.945359,"twenty":-5.517241,"median":-3.524616,"eighty":-2.692521,"marketCap":130725631},{"date":"2022-06-24","current":-4.576507,"twenty":-5.506943,"median":-3.528816,"eighty":-2.697361,"marketCap":120975377},{"date":"2022-07-01","current":-5.000004,"twenty":-5.493544,"median":-3.537637,"eighty":-2.709722,"marketCap":132170113},{"date":"2022-07-08","current":-4.781425,"twenty":-5.484246,"median":-3.546594,"eighty":-2.718006,"marketCap":126392185},{"date":"2022-07-15","current":-5.669404,"twenty":-5.495944,"median":-3.55555,"eighty":-2.720535,"marketCap":149865019},{"date":"2022-07-22","current":-5.751371,"twenty":-5.50981,"median":-3.557831,"eighty":-2.72236,"marketCap":152031743},{"date":"2022-07-29","current":-5.62842,"twenty":-5.521806,"median":-3.569598,"eighty":-2.72966,"marketCap":148781658},{"date":"2022-08-05","current":-5.614759,"twenty":-5.538956,"median":-3.572606,"eighty":-2.729904,"marketCap":148420537},{"date":"2022-08-12","current":-5.177116,"twenty":-5.585722,"median":-3.582418,"eighty":-2.730879,"marketCap":152491966},{"date":"2022-08-19","current":-4.864159,"twenty":-5.554973,"median":-3.582961,"eighty":-2.73263,"marketCap":143273790},{"date":"2022-08-26","current":-5.054436,"twenty":-5.538956,"median":-3.590365,"eighty":-2.739632,"marketCap":148878412},{"date":"2022-09-02","current":-4.944024,"twenty":-5.52783,"median":-3.594795,"eighty":-2.741382,"marketCap":145626214},{"date":"2022-09-09","current":-4.441034,"twenty":-5.524759,"median":-3.617061,"eighty":-2.748384,"marketCap":130810643},{"date":"2022-09-16","current":-5.164848,"twenty":-5.524089,"median":-3.625383,"eighty":-2.749506,"marketCap":152130610},{"date":"2022-09-23","current":-6.03588,"twenty":-5.541545,"median":-3.627198,"eighty":-2.757137,"marketCap":177786842},{"date":"2022-09-30","current":-5.177116,"twenty":-5.541545,"median":-3.634103,"eighty":-2.757137,"marketCap":152491966},{"date":"2022-10-07","current":-5.042168,"twenty":-5.528598,"median":-3.645094,"eighty":-2.757225,"marketCap":148517057},{"date":"2022-10-14","current":-4.281549,"twenty":-5.524759,"median":-3.668691,"eighty":-2.760802,"marketCap":126113024},{"date":"2022-10-21","current":-4.294907,"twenty":-5.524089,"median":-3.689131,"eighty":-2.764665,"marketCap":126506471},{"date":"2022-10-28","current":-3.810196,"twenty":-5.512676,"median":-3.723291,"eighty":-2.765803,"marketCap":112229312},{"date":"2022-11-04","current":-3.552501,"twenty":-5.505469,"median":-3.689131,"eighty":-2.76589,"marketCap":104638923},{"date":"2022-11-11","current":-3.177192,"twenty":-5.498344,"median":-3.683931,"eighty":-2.76589,"marketCap":103735306},{"date":"2022-11-18","current":-2.82294,"twenty":-5.486343,"median":-3.679266,"eighty":-2.771347,"marketCap":92169000},{"date":"2022-11-25","current":-2.225141,"twenty":-5.479786,"median":-3.651186,"eighty":-2.765575,"marketCap":72650859},{"date":"2022-12-02","current":-2.49083,"twenty":-5.476314,"median":-3.635237,"eighty":-2.757137,"marketCap":81325588},{"date":"2022-12-09","current":-2.070156,"twenty":-5.46676,"median":-3.631076,"eighty":-2.739632,"marketCap":67590600},{"date":"2022-12-16","current":-1.749116,"twenty":-5.455591,"median":-3.627198,"eighty":-2.72966,"marketCap":57108635},{"date":"2022-12-23","current":-1.428076,"twenty":-5.446029,"median":-3.624877,"eighty":-2.714823,"marketCap":46626670},{"date":"2022-12-30","current":-1.372724,"twenty":-5.440457,"median":-3.617061,"eighty":-2.690054,"marketCap":44819435},{"date":"2023-01-06","current":-1.54985,"twenty":-5.431327,"median":-3.594795,"eighty":-2.675801,"marketCap":50602588},{"date":"2023-01-13","current":-2.435478,"twenty":-5.417741,"median":-3.590365,"eighty":-2.658473,"marketCap":79518353},{"date":"2023-01-20","current":-2.944714,"twenty":-5.409268,"median":-3.583179,"eighty":-2.657679,"marketCap":96144917},{"date":"2023-01-27","current":-3.642146,"twenty":-5.396954,"median":-3.583179,"eighty":-2.662233,"marketCap":118916082},{"date":"2023-02-03","current":-3.166121,"twenty":-5.394079,"median":-3.58307,"eighty":-2.667971,"marketCap":103373859},{"date":"2023-02-10","current":-3.027742,"twenty":-5.385049,"median":-3.582418,"eighty":-2.66929,"marketCap":98855770},{"date":"2023-02-17","current":-3.077558,"twenty":-5.382548,"median":-3.580179,"eighty":-2.673323,"marketCap":100482282},{"date":"2023-02-24","current":-2.81187,"twenty":-5.382518,"median":-3.572606,"eighty":-2.670844,"marketCap":91807553},{"date":"2023-03-03","current":-3.055418,"twenty":-5.374659,"median":-3.570908,"eighty":-2.683237,"marketCap":99759388},{"date":"2023-03-10","current":-2.18086,"twenty":-5.368857,"median":-3.558005,"eighty":-2.668901,"marketCap":71205070},{"date":"2023-03-17","current":-1.860252,"twenty":-5.364302,"median":-3.55555,"eighty":-2.656885,"marketCap":68674941},{"date":"2023-03-24","current":-2.694263,"twenty":-5.363415,"median":-3.553043,"eighty":-2.656885,"marketCap":99464089},{"date":"2023-03-31","current":-3.081793,"twenty":-5.361062,"median":-3.546594,"eighty":-2.660856,"marketCap":113770568},{"date":"2023-04-06","current":-2.786532,"twenty":-5.356369,"median":-3.537637,"eighty":-2.666362,"marketCap":102870394},{"date":"2023-04-14","current":-2.768078,"twenty":-5.344267,"median":-3.528816,"eighty":-2.666362,"marketCap":102189133},{"date":"2023-04-21","current":-2.987679,"twenty":-5.332053,"median":-3.524531,"eighty":-2.668669,"marketCap":110296138},{"date":"2023-04-28","current":-2.860347,"twenty":-5.325403,"median":-3.515675,"eighty":-2.670455,"marketCap":105595437},{"date":"2023-05-05","current":-2.841893,"twenty":-5.316236,"median":-3.510769,"eighty":-2.680758,"marketCap":104914177},{"date":"2023-05-11","current":-2.49127,"twenty":-5.314212,"median":-3.509238,"eighty":-2.670844,"marketCap":91970220},{"date":"2023-05-19","current":-1.102154,"twenty":-5.314212,"median":-3.499404,"eighty":-2.656885,"marketCap":46988117},{"date":"2023-05-26","current":-1.186935,"twenty":-5.284707,"median":-3.490884,"eighty":-2.645999,"marketCap":50602588},{"date":"2023-06-02","current":-1.271716,"twenty":-5.275525,"median":-3.48094,"eighty":-2.634543,"marketCap":54217059},{"date":"2023-06-09","current":-1.322584,"twenty":-5.270681,"median":-3.470048,"eighty":-2.626758,"marketCap":56385741},{"date":"2023-06-16","current":-1.220847,"twenty":-5.263333,"median":-3.448825,"eighty":-2.608444,"marketCap":52048376},{"date":"2023-06-23","current":-1.237803,"twenty":-5.25603,"median":-3.445124,"eighty":-2.600419,"marketCap":52771270},{"date":"2023-06-30","current":-1.051115,"twenty":-5.250613,"median":-3.439121,"eighty":-2.587838,"marketCap":44812206},{"date":"2023-07-07","current":-0.974982,"twenty":-5.250167,"median":-3.431946,"eighty":-2.571464,"marketCap":41566411},{"date":"2023-07-14","current":-1.000416,"twenty":-5.235144,"median":-3.4225,"eighty":-2.55252,"marketCap":42650753},{"date":"2023-07-21","current":-1.017373,"twenty":-5.213921,"median":-3.421209,"eighty":-2.546619,"marketCap":43373647},{"date":"2023-07-28","current":-2.111048,"twenty":-5.194754,"median":-3.416227,"eighty":-2.531091,"marketCap":90000317},{"date":"2023-08-04","current":-3.128421,"twenty":-5.191297,"median":-3.415081,"eighty":-2.525399,"marketCap":133373965},{"date":"2023-08-11","current":-3.425155,"twenty":-5.177424,"median":-3.412253,"eighty":-2.529787,"marketCap":146024612},{"date":"2023-08-18","current":-3.850712,"twenty":-5.177116,"median":-3.415178,"eighty":-2.531091,"marketCap":142341585},{"date":"2023-08-25","current":-2.844054,"twenty":-5.177116,"median":-3.415129,"eighty":-2.534656,"marketCap":105130460},{"date":"2023-09-01","current":-3.38159,"twenty":-5.172266,"median":-3.412253,"eighty":-2.546181,"marketCap":125000478},{"date":"2023-09-08","current":-2.990655,"twenty":-5.166332,"median":-3.406766,"eighty":-2.546531,"marketCap":110549556},{"date":"2023-09-15","current":-2.863601,"twenty":-5.16423,"median":-3.398819,"eighty":-2.546619,"marketCap":105853006},{"date":"2023-09-22","current":-2.589946,"twenty":-5.163966,"median":-3.388956,"eighty":-2.546619,"marketCap":95737360},{"date":"2023-09-29","current":-2.756094,"twenty":-5.15301,"median":-3.380585,"eighty":-2.546619,"marketCap":101879002},{"date":"2023-10-06","current":-2.541079,"twenty":-5.138882,"median":-3.37292,"eighty":-2.546619,"marketCap":93930995},{"date":"2023-10-13","current":-2.120824,"twenty":-5.129642,"median":-3.359509,"eighty":-2.546531,"marketCap":78396254},{"date":"2023-10-20","current":-1.93513,"twenty":-5.127388,"median":-3.354526,"eighty":-2.53083,"marketCap":71532065},{"date":"2023-10-27","current":-2.032863,"twenty":-5.122481,"median":-3.349561,"eighty":-2.526277,"marketCap":75144796},{"date":"2023-11-03","current":-2.238202,"twenty":-5.095964,"median":-3.331648,"eighty":-2.509649,"marketCap":82735143},{"date":"2023-11-10","current":-2.326065,"twenty":-5.063857,"median":-3.322692,"eighty":-2.503799,"marketCap":85982988},{"date":"2023-11-17","current":-1.220189,"twenty":-5.055842,"median":-3.321106,"eighty":-2.491241,"marketCap":72615885},{"date":"2023-11-24","current":-1.232987,"twenty":-5.054649,"median":-3.313684,"eighty":-2.490718,"marketCap":73377545},{"date":"2023-12-01","current":-1.330169,"twenty":-5.054649,"median":-3.311804,"eighty":-2.473168,"marketCap":79160997},{"date":"2023-12-08","current":-1.694598,"twenty":-5.054436,"median":-3.297395,"eighty":-2.435478,"marketCap":100848941},{"date":"2023-12-15","current":-1.652082,"twenty":-5.054436,"median":-3.286958,"eighty":-2.404258,"marketCap":98318681},{"date":"2023-12-22","current":-1.451645,"twenty":-5.049539,"median":-3.277105,"eighty":-2.391325,"marketCap":86390311},{"date":"2023-12-29","current":-1.943625,"twenty":-5.049539,"median":-3.273518,"eighty":-2.373339,"marketCap":115669036},{"date":"2024-01-05","current":-1.943625,"twenty":-5.048065,"median":-3.270913,"eighty":-2.35083,"marketCap":115669036},{"date":"2024-01-12","current":-2.210874,"twenty":-5.036541,"median":-3.268956,"eighty":-2.325032,"marketCap":131573529},{"date":"2024-01-19","current":-2.338424,"twenty":-5.014034,"median":-3.262115,"eighty":-2.313704,"marketCap":139164309},{"date":"2024-01-26","current":-2.368793,"twenty":-5.000004,"median":-3.247199,"eighty":-2.323001,"marketCap":140971638},{"date":"2024-02-02","current":-2.350572,"twenty":-5.000004,"median":-3.238636,"eighty":-2.323001,"marketCap":139887241},{"date":"2024-02-09","current":-2.405236,"twenty":-4.993096,"median":-3.231278,"eighty":-2.323001,"marketCap":143140433},{"date":"2024-02-16","current":-1.955773,"twenty":-4.993096,"median":-3.221138,"eighty":-2.301981,"marketCap":116391968},{"date":"2024-02-23","current":-1.761411,"twenty":-4.987694,"median":-3.210403,"eighty":-2.300711,"marketCap":104825064},{"date":"2024-03-01","current":-2.393089,"twenty":-4.981931,"median":-3.206466,"eighty":-2.295826,"marketCap":142417501},{"date":"2024-03-08","current":-2.156209,"twenty":-4.971014,"median":-3.203172,"eighty":-2.291217,"marketCap":128320337},{"date":"2024-03-15","current":-2.052954,"twenty":-4.949999,"median":-3.198232,"eighty":-2.270397,"marketCap":122175420},{"date":"2024-03-22","current":-1.931796,"twenty":-4.944291,"median":-3.196944,"eighty":-2.246235,"marketCap":133380858},{"date":"2024-03-28","current":-2.146557,"twenty":-4.944024,"median":-3.179396,"eighty":-2.237373,"marketCap":148209009},{"date":"2024-04-05","current":-1.947608,"twenty":-4.944024,"median":-3.173816,"eighty":-2.222508,"marketCap":134472565},{"date":"2024-04-12","current":-1.732952,"twenty":-4.936663,"median":-3.16852,"eighty":-2.207447,"marketCap":119651664},{"date":"2024-04-19","current":-1.335054,"twenty":-4.917361,"median":-3.166078,"eighty":-2.194783,"marketCap":92178774},{"date":"2024-04-26","current":-1.325001,"twenty":-4.907437,"median":-3.162112,"eighty":-2.18408,"marketCap":91484722},{"date":"2024-05-03","current":-1.30386,"twenty":-4.907219,"median":-3.153872,"eighty":-2.174144,"marketCap":90024996},{"date":"2024-05-10","current":-1.481151,"twenty":-4.907219,"median":-3.143981,"eighty":-2.158719,"marketCap":117864051},{"date":"2024-05-17","current":-1.204003,"twenty":-4.907219,"median":-3.143981,"eighty":-2.15378,"marketCap":95809735},{"date":"2024-05-24","current":-1.181286,"twenty":-4.907219,"median":-3.143981,"eighty":-2.15378,"marketCap":94002004},{"date":"2024-05-31","current":-1.22672,"twenty":-4.907219,"median":-3.143981,"eighty":-2.146826,"marketCap":97617465},{"date":"2024-06-07","current":-1.167656,"twenty":-4.907219,"median":-3.143981,"eighty":-2.146826,"marketCap":92917365},{"date":"2024-06-14","current":-1.303958,"twenty":-4.907219,"median":-3.145723,"eighty":-2.14815,"marketCap":103763750},{"date":"2024-06-21","current":-1.284512,"twenty":-4.907219,"median":-3.147465,"eighty":-2.151351,"marketCap":102216333},{"date":"2024-06-28","current":-1.258524,"twenty":-4.907219,"median":-3.153872,"eighty":-2.157715,"marketCap":100148289},{"date":"2024-07-05","current":-1.149482,"twenty":-4.907219,"median":-3.153872,"eighty":-2.146718,"marketCap":91471181},{"date":"2024-07-12","current":-1.363022,"twenty":-4.907219,"median":-3.153872,"eighty":-2.144062,"marketCap":108463851},{"date":"2024-07-15","current":-1.431173,"twenty":-4.907219,"median":-3.153872,"eighty":-2.144062,"marketCap":113887043},{"date":"2024-08-02","current":-1.24035,"twenty":-4.931755,"median":-3.162112,"eighty":-2.150136,"marketCap":98702104},{"date":"2024-08-09","current":-1.163112,"twenty":-4.931755,"median":-3.143981,"eighty":-2.125508,"marketCap":92555819},{"date":"2024-08-16","current":-1.315831,"twenty":-4.931755,"median":-3.13291,"eighty":-2.111048,"marketCap":88217265},{"date":"2024-08-23","current":-1.192736,"twenty":-4.931755,"median":-3.127325,"eighty":-2.089397,"marketCap":79964578},{"date":"2024-08-30","current":-1.333058,"twenty":-4.931755,"median":-3.106614,"eighty":-2.052954,"marketCap":89372175},{"date":"2024-09-06","current":-1.295279,"twenty":-4.931755,"median":-3.082084,"eighty":-2.041847,"marketCap":86839360},{"date":"2024-09-13","current":-1.187339,"twenty":-4.931755,"median":-3.077558,"eighty":-2.018661,"marketCap":79602747},{"date":"2024-09-20","current":-1.20353,"twenty":-4.931755,"median":-3.063486,"eighty":-2.003133,"marketCap":80688239},{"date":"2024-09-27","current":-1.235912,"twenty":-4.931755,"median":-3.055418,"eighty":-1.96276,"marketCap":82859223},{"date":"2024-10-04","current":-1.241309,"twenty":-4.931755,"median":-3.053472,"eighty":-1.943625,"marketCap":83221054},{"date":"2024-10-11","current":-1.268294,"twenty":-4.931755,"median":-3.04598,"eighty":-1.925492,"marketCap":85030207},{"date":"2024-10-18","current":-1.27396,"twenty":-4.931755,"median":-3.037227,"eighty":-1.904643,"marketCap":85410129},{"date":"2024-10-25","current":-1.289828,"twenty":-4.931755,"median":-3.027742,"eighty":-1.890017,"marketCap":86473911},{"date":"2024-10-31","current":-1.241309,"twenty":-4.931755,"median":-3.022207,"eighty":-1.868013,"marketCap":83221054},{"date":"2024-11-08","current":-1.208927,"twenty":-4.934209,"median":-3.009966,"eighty":-1.839507,"marketCap":81050070},{"date":"2024-11-15","current":-2.344381,"twenty":-4.934209,"median":-2.995939,"eighty":-1.81136,"marketCap":96970619},{"date":"2024-11-22","current":-1.837015,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":75984440},{"date":"2024-11-29","current":-2.011969,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":83221054},{"date":"2024-12-06","current":-1.898249,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":78517255},{"date":"2024-12-13","current":-1.837015,"twenty":-4.934209,"median":-2.995939,"eighty":-1.80821,"marketCap":75984440},{"date":"2024-12-20","current":-1.732042,"twenty":-4.934209,"median":-2.995939,"eighty":-1.791517,"marketCap":71642472},{"date":"2024-12-27","current":-1.767033,"twenty":-4.934209,"median":-2.995939,"eighty":-1.778768,"marketCap":73089795},{"date":"2025-01-03","current":-1.704925,"twenty":-4.934209,"median":-2.995939,"eighty":-1.762398,"marketCap":70520797},{"date":"2025-01-10","current":-1.810772,"twenty":-4.936663,"median":-2.995939,"eighty":-1.765278,"marketCap":74898948},{"date":"2025-01-17","current":-1.784529,"twenty":-4.936663,"median":-2.995939,"eighty":-1.762151,"marketCap":73813456},{"date":"2025-01-24","current":-1.906996,"twenty":-4.936663,"median":-2.995939,"eighty":-1.765283,"marketCap":78879086},{"date":"2025-01-31","current":-1.793276,"twenty":-4.936663,"median":-2.995939,"eighty":-1.767033,"marketCap":74175287},{"date":"2025-02-07","current":-1.784529,"twenty":-4.936663,"median":-2.995939,"eighty":-1.767033,"marketCap":73813456},{"date":"2025-02-14","current":-1.74079,"twenty":-4.936663,"median":-2.995939,"eighty":-1.762151,"marketCap":72004303},{"date":"2025-02-21","current":-1.758286,"twenty":-4.936663,"median":-2.995939,"eighty":-1.75127,"marketCap":72727964},{"date":"2025-02-28","current":-1.819519,"twenty":-4.936663,"median":-2.995939,"eighty":-1.75127,"marketCap":75260779},{"date":"2025-03-07","current":-1.837015,"twenty":-4.939116,"median":-2.995939,"eighty":-1.749285,"marketCap":75984440},{"date":"2025-03-14","current":-1.723295,"twenty":-4.939116,"median":-2.995939,"eighty":-1.74079,"marketCap":71280641},{"date":"2025-03-21","current":-1.758286,"twenty":-4.939116,"median":-2.995939,"eighty":-1.74079,"marketCap":72727964},{"date":"2025-03-28","current":-3.156359,"twenty":-4.939116,"median":-3.018954,"eighty":-1.74412,"marketCap":59705678},{"date":"2025-04-04","current":-2.524934,"twenty":-4.939116,"median":-3.018954,"eighty":-1.74412,"marketCap":47761648},{"date":"2025-04-11","current":-1.729197,"twenty":-4.936663,"median":-2.995939,"eighty":-1.74079,"marketCap":32709492},{"date":"2025-04-17","current":-2.257138,"twenty":-4.936663,"median":-2.990655,"eighty":-1.74079,"marketCap":42696019}],"updateTime":1745021284760}}}